Skip to main content


Fig. 7 | Journal of Analytical Science and Technology

Fig. 7

From: Application of electric cell-substrate impedance sensing toward personalized anti-cancer therapeutic selection

Fig. 7

Cellular responses to combination drug treatments. RTCA cell index curves of metastatic prostate cancer cell lines treated with a combination of sunitinib malate and docetaxel. a The response of the DU145 cell line to the combination sunitinib malate at 5 μg/mL and serial dilutions of docetaxel. b The PC-3 cell line response to 0.12 μM docetaxel combined with serial dilutions of sunitinib malate

Back to article page